These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 21424675)

  • 1. Functional adiponectin resistance and exercise intolerance in heart failure.
    Van Berendoncks AM; Conraads VM
    Curr Heart Fail Rep; 2011 Jun; 8(2):113-22. PubMed ID: 21424675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adiponectin: key role and potential target to reverse energy wasting in chronic heart failure.
    Van Berendoncks AM; Garnier A; Ventura-Clapier R; Conraads VM
    Heart Fail Rev; 2013 Sep; 18(5):557-66. PubMed ID: 23090715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional adiponectin resistance at the level of the skeletal muscle in mild to moderate chronic heart failure.
    Van Berendoncks AM; Garnier A; Beckers P; Hoymans VY; Possemiers N; Fortin D; Martinet W; Van Hoof V; Vrints CJ; Ventura-Clapier R; Conraads VM
    Circ Heart Fail; 2010 Mar; 3(2):185-94. PubMed ID: 20103776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exercise training reverses adiponectin resistance in skeletal muscle of patients with chronic heart failure.
    Van Berendoncks AM; Garnier A; Beckers P; Hoymans VY; Possemiers N; Fortin D; Van Hoof V; Dewilde S; Vrints CJ; Ventura-Clapier R; Conraads VM
    Heart; 2011 Sep; 97(17):1403-9. PubMed ID: 21685184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unraveling new mechanisms of exercise intolerance in chronic heart failure: role of exercise training.
    Conraads VM; Van Craenenbroeck EM; De Maeyer C; Van Berendoncks AM; Beckers PJ; Vrints CJ
    Heart Fail Rev; 2013 Jan; 18(1):65-77. PubMed ID: 22684340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced glucose transporter GLUT4 in skeletal muscle predicts insulin resistance in non-diabetic chronic heart failure patients independently of body composition.
    Doehner W; Gathercole D; Cicoira M; Krack A; Coats AJ; Camici PG; Anker SD
    Int J Cardiol; 2010 Jan; 138(1):19-24. PubMed ID: 18778861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein catabolism and impairment of skeletal muscle insulin signalling in heart failure.
    Schulze PC
    Clin Sci (Lond); 2010 Aug; 119(11):465-6. PubMed ID: 20629636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Capillary density of skeletal muscle: a contributing mechanism for exercise intolerance in class II-III chronic heart failure independent of other peripheral alterations.
    Duscha BD; Kraus WE; Keteyian SJ; Sullivan MJ; Green HJ; Schachat FH; Pippen AM; Brawner CA; Blank JM; Annex BH
    J Am Coll Cardiol; 1999 Jun; 33(7):1956-63. PubMed ID: 10362199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exercise intolerance in chronic heart failure--skeletal muscle dysfunction and potential therapies.
    Okita K; Kinugawa S; Tsutsui H
    Circ J; 2013; 77(2):293-300. PubMed ID: 23337207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adiponectin resistance in skeletal muscle: pathophysiological implications in chronic heart failure.
    Sente T; Van Berendoncks AM; Hoymans VY; Vrints CJ
    J Cachexia Sarcopenia Muscle; 2016 Jun; 7(3):261-74. PubMed ID: 27239409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiology of human heart failure: importance of skeletal muscle myopathy and reflexes.
    Piepoli MF; Crisafulli A
    Exp Physiol; 2014 Apr; 99(4):609-15. PubMed ID: 24293507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exercise intolerance in chronic heart failure: the role of cortisol and the catabolic state.
    Tzanis G; Dimopoulos S; Agapitou V; Nanas S
    Curr Heart Fail Rep; 2014 Mar; 11(1):70-9. PubMed ID: 24293034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exercise intolerance in patients with chronic heart failure.
    Sullivan MJ; Hawthorne MH
    Prog Cardiovasc Dis; 1995; 38(1):1-22. PubMed ID: 7631018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normal skeletal muscle Na(+)-K(+) pump concentration in patients with chronic heart failure.
    Green HJ; Duscha BD; Sullivan MJ; Keteyian SJ; Kraus WE
    Muscle Nerve; 2001 Jan; 24(1):69-76. PubMed ID: 11150968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart Failure-Induced Skeletal Muscle Wasting.
    Philippou A; Xanthis D; Chryssanthopοulos C; Maridaki M; Koutsilieris M
    Curr Heart Fail Rep; 2020 Oct; 17(5):299-308. PubMed ID: 32743732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart failure: a model of cardiac and skeletal muscle energetic failure.
    Mettauer B; Zoll J; Garnier A; Ventura-Clapier R
    Pflugers Arch; 2006 Sep; 452(6):653-66. PubMed ID: 16767467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adiponectin resistance in heart failure and the emerging pattern of metabolic failure in chronic heart failure.
    Springer J; Anker SD; Doehner W
    Circ Heart Fail; 2010 Mar; 3(2):181-2. PubMed ID: 20233990
    [No Abstract]   [Full Text] [Related]  

  • 18. Reduced exercise tolerance in CHF may be related to factors other than impaired skeletal muscle oxidative capacity.
    Williams AD; Selig S; Hare DL; Hayes A; Krum H; Patterson J; Geerling RH; Toia D; Carey MF
    J Card Fail; 2004 Apr; 10(2):141-8. PubMed ID: 15101026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of exercise training on skeletal muscle fibre characteristics in men with chronic heart failure. Correlation between skeletal muscle alterations, cytokines and exercise capacity.
    Larsen AI; Lindal S; Aukrust P; Toft I; Aarsland T; Dickstein K
    Int J Cardiol; 2002 Apr; 83(1):25-32. PubMed ID: 11959380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of adipokines as regulators of skeletal muscle fatty acid metabolism and insulin sensitivity.
    Dyck DJ; Heigenhauser GJ; Bruce CR
    Acta Physiol (Oxf); 2006 Jan; 186(1):5-16. PubMed ID: 16497175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.